2 showed that SMG‐1 suppressed oncogenic CDK2‐driven proliferation and was a tumor suppressor in osteosarcoma. Similarly, in human papillomavirus (HPV)‐positive head and neck squamous cell carcinoma, SMG‐1 was underexpressed and exhibited tumor‐suppressive activity 3. This evidence concerns the gene CDK2 and neoplasm.